Posted in | News | Nanomedicine | Nanoanalysis

UMass Faculty Awarded CVIP Technology Development Fund Grant for Nanoparticle Technology

Four UMass Medical School faculty members have received 2013 Commercial Ventures and Intellectual Property (CVIP) Technology Development Fund grants awarded by the UMass President’s Office.

To advance commercialization of discoveries made on the five UMass campuses, the CVIP Technology Development fund was established in 2004 to provide UMass researchers with supplemental funding to help close the gap between research discovery and proven technology. This year, eight awards of $25,000 each are being made to faculty members from the Amherst, Boston, Lowell and Worcester campuses.

Awardees from the UMMS are Gang Han, PhD, assistant professor of biochemistry & molecular pharmacology; Jie Song, PhD, assistant professor of orthopedics & physical rehabilitation and cell & developmental biology; Stephen Miller, PhD, associate professor of biochemistry & molecular pharmacology; and, in a collaboration with a colleague from UMass Lowell, Paul Kaufman, PhD, professor of molecular medicine.

“These are the discoveries that help change the world for the better, create new jobs and businesses and make us very proud of the groundbreaking work being done on the campuses of the University of Massachusetts,” said President Caret of the award-winning projects.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.